These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 20442590)

  • 1. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
    Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
    Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
    Geng D; Song X; Ning F; Song Q; Yin H
    Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
    Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.
    Sellors JW; Schweizer JG; Lu PS; Liu B; Weigl BH; Cui JF; Peck RB; Lewis K; Lim J; Howard M; Mahoney CW; McAllister L; Berard-Bergery M; Bry C; Labiad YA; Li H; Liu L; Silver J; Chen W; Qiao YL
    J Low Genit Tract Dis; 2011 Apr; 15(2):169-76. PubMed ID: 21478701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles are altered in human papillomavirus-16 E6 D25E-expressing cell lines.
    Jang M; Rhee JE; Jang DH; Kim SS
    Virol J; 2011 Sep; 8():453. PubMed ID: 21943319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.
    Piyathilake CJ; Macaluso M; Alvarez RD; Chen M; Badiga S; Edberg JC; Partridge EE; Johanning GL
    Cancer; 2011 Mar; 117(5):957-63. PubMed ID: 20945322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
    Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
    Au Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
    Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
    Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Wang X; Meyers C; Guo M; Zheng ZM
    Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
    Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
    Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts.
    Häfner N; Driesch C; Gajda M; Jansen L; Kirchmayr R; Runnebaum IB; Dürst M
    Oncogene; 2008 Mar; 27(11):1610-7. PubMed ID: 17828299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
    Li BH; Zhou JS; Ye F; Cheng XD; Zhou CY; Lu WG; Xie X
    Eur J Cancer; 2011 Sep; 47(14):2166-74. PubMed ID: 21636267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
    Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
    Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.